Clinical Trials in Houston

Showing 8321-8340 of 17,885 trials

Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission

NCT02126553

This phase II trial studies how well lenalidomide works in treating patients with acute myeloid leukemia that have had a decrease in or disappearance of signs and symptoms of cancer, although cancer still may be in the body and may be likely to come back or spread. Biological therapies, such as lenalidomide, use substances made from living organisms that may kill cancer cells by blocking blood flow to the cancer and by stimulating white blood cells to kill the cancer cells.

Alkylating Agent-Related Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia

M.D. Anderson Cancer Center29 participantsStarted Nov 2014

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients

NCT01568866

The primary objective of this study was to compare progression-free survival in patients with multiple myeloma who relapsed after 1 to 3 prior therapies treated with carfilzomib plus dexamethasone or bortezomib plus dexamethasone.

Multiple Myeloma

Amgen929 participantsStarted Jun 2012

Burbank, California, United States • La Jolla, California, United States • Los Angeles, California, United States +238 more locations

Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission

Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients

Find Trials by Condition in Houston

Vascular Inflammation in Psoriasis - Apremilast

Stroke Telemedicine Outpatient Prevention Program for Blood Pressure Reduction

Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

Negative Pressure Applied by the Equinox MPD for Severe Open Angle Glaucoma

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease

Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC